CN Stock MarketDetailed Quotes

Kexing Biopharm (688136)

Watchlist
  • 24.68
  • -1.11-4.30%
Market Closed May 20 15:00 CST
4.97BMarket Cap44.31P/E (TTM)

Kexing Biopharm (688136) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
血液644.72M42.03%
肿瘤与免疫440.11M28.69%
Antivirus277.01M18.06%
Other151.9M9.90%
Total special adjustments14.55M0.95%
Other business5.73M0.37%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
医药产品相关1.51B98.68%
Other14.55M0.95%
Other business5.73M0.37%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Domestic1.16B75.75%
Abroad366.29M23.88%
Other business5.73M0.37%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More